Storer BE - Search Results

1

Design and analysis of phase I clinical trials.

Storer BE. Storer BE. Biometrics. 1989 Sep;45(3):925-37. Biometrics. 1989. PMID: 2790129

2

An evaluation of phase I clinical trial designs in the continuous dose-response setting.

Storer BE. Storer BE. Stat Med. 2001 Aug 30;20(16):2399-408. doi: 10.1002/sim.903. Stat Med. 2001. PMID: 11512130

3

A phase I study of Topotecan, as a radiosensitizer, for thoracic malignancies.

Forouzannia A, Schiller J, Berlin J, Hutson P, Boothman D, Storer B, Wilding G, Mehta M. Forouzannia A, et al. Lung Cancer. 2004 Apr;44(1):111-9. doi: 10.1016/j.lungcan.2003.10.005. Lung Cancer. 2004. PMID: 15013589 Clinical Trial.

4

Small-sample confidence sets for the MTD in a phase I clinical trial.

Storer BE. Storer BE. Biometrics. 1993 Dec;49(4):1117-25. Biometrics. 1993. PMID: 8117905

Properties of procedures for interval estimation of the maximum tolerable dose (MTD) in a Phase I clinical trial are examined, using a two-stage stochastic sampling scheme (Storer, 1989) as a paradigm for development. Although the likelihood function for the data arising f …

Properties of procedures for interval estimation of the maximum tolerable dose (MTD) in a Phase I clinical trial are examined, using a two-s …

5

A sequential phase II/III trial for binary outcomes.

Storer BE. Storer BE. Stat Med. 1990 Mar;9(3):229-35. doi: 10.1002/sim.4780090305. Stat Med. 1990. PMID: 2160719

6

A class of phase II designs with three possible outcomes.

Storer BE. Storer BE. Biometrics. 1992 Mar;48(1):55-60. Biometrics. 1992. PMID: 1581493

7

Altered tryptophan and neopterin metabolism in cancer patients treated with recombinant interleukin 2.

Brown RR, Lee CM, Kohler PC, Hank JA, Storer BE, Sondel PM. Brown RR, et al. Among authors: storer be. Cancer Res. 1989 Sep 1;49(17):4941-4. Cancer Res. 1989. PMID: 2788032

8

Biological and clinical effects of interferon-beta ser at two doses.

Borden EC, Rinehart JJ, Storer BE, Trump DL, Paulnock DM, Teitelbaum AP. Borden EC, et al. Among authors: storer be. J Interferon Res. 1990 Dec;10(6):559-70. doi: 10.1089/jir.1990.10.559. J Interferon Res. 1990. PMID: 2086672 Clinical Trial.

9

Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly.

Schiller JH, Storer BE, Witt PL, Alberti D, Tombes MB, Arzoomanian R, Proctor RA, McCarthy D, Brown RR, Voss SD, et al. Schiller JH, et al. Among authors: storer be. Cancer Res. 1991 Mar 15;51(6):1651-8. Cancer Res. 1991. PMID: 1998956 Clinical Trial.

10

Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients.

Albertini MR, Hank JA, Schiller JH, Khorsand M, Borchert AA, Gan J, Bechhofer R, Storer B, Reisfeld RA, Sondel PM. Albertini MR, et al. Clin Cancer Res. 1997 Aug;3(8):1277-88. Clin Cancer Res. 1997. PMID: 9815810 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results